ADC Contract Manufacturing Market Size, Share, Trends By 2035

In order to mitigate the challenges associated with ADC manufacturing, around 70-80% of the therapeutics developers prefer to outsource their operations to contract manufacturing organizations (CMOs), which claim to have the required expertise and experience to leverage their capabilities and yield cost savings opportunities.

The financial opportunity within the ADC contract market has been analyzed across the following segments:

Scale of Operation
Commercial
Clinical

Phase of Development
Phase III
Phase II
Phase I

Type of Component Manufacturing
Antibody manufacturing
HPAPI / Cytotoxic Payload and Linker Manufacturing
Conjugation
Fill / Finish

Target Indication
Solid Tumors
Hematological Malignancies
Others

Type of Payload Used
Maytansinoid
Auristatin
Camptothecin
PBD
Others

Type of Linker Used
SMCC
VC
Malemide
Peptide Linker
Others

Type of Antibody Origin
Humanized
Chimeric
Murine
Human
Others

Type of Antibody Isotype
IgG1
Others

Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World

The ADC Contract Manufacturing Market (5^th Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:

MabPlex
AbbVie Contract Manufacturing
Lonza
Catalent Pharma Solutions
Goodwin Biotechnology
MilliporeSigma
Piramal Pharma Solutions
Wuxi Biologics
Abzena
CARBOGEN AMCIS
Cerbios-Pharma
Formosa Laboratories
Creative Biolabs
Novasep
Sterling Pharma Solutions

Table of Contents

PREFACE

EXECUTIVE SUMMARY

INTRODUCTION

ADC CONTRACT MANUFACTURING SERVICE PROVIDERS: MARKET LANDSCAPE

COMPANY PROFILES

COMPANY COMPETITIVENESS ANALYSIS

ADC CONTRACT MANUFACTURING SERVICE PROVIDERS: RECENT EXPANSIONS

ADC CONTRACT MANUFACTURING SERVICE PROVIDERS: PARTNERSHIPS AND COLLABORATIONS

MAKE VERSUS BUY DECISION MAKING

VALUE CHAIN ANALYSIS

ADC MANUFACTURING: CAPACITY ANALYSIS

ADC THERAPEUTICS: MARKET OVERVIEW

NOVEL ADC CONJUGATION TECHNOLOGY PLATFORMS

CLINICAL TRIALS ANALYSIS

LIKELY PARTNER ANALYSIS

ADC THERAPEUTICS: DEMAND ANALYSIS

REGIONAL CAPABILITY ASSESSMENT ANALYSIS

ATTRACTIVENESS COMPETETIVENESS MATRIX

MARKET SIZING AND OPPORTUNITY ANALYSIS

SWOT ANALYSIS

CONCLUDING REMARKS

INTERVIEW TRANSCRIPTS

APPENDIX I: TABULATED DATA

APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/view_document/adc-contract-manufacturing-market/218.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com